A R Winstock

Summary

Affiliation: New South Wales
Country: Australia

Publications

  1. ncbi 4-MTA: a new synthetic drug on the dance scene
    Adam R Winstock
    National Addiction Centre, Institute of Psychiatry, Addiction Sciences Building, 4 Windsor Walk, SE5 8AF, London, UK
    Drug Alcohol Depend 67:111-5. 2002
  2. doi Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study
    A R Winstock
    National Drug and Alcohol Research Centre, University of New South Wales, and Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
    J Psychopharmacol 23:84-93. 2009
  3. doi Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, Australia
    Drug Alcohol Rev 27:393-7. 2008
  4. ncbi The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Australia
    Drug Alcohol Rev 26:411-6. 2007
  5. ncbi Safe storage of methadone takeaway doses - a survey of patient practice
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Ashfield, New South Wales, Australia
    Aust N Z J Public Health 31:526-8. 2007
  6. doi Opioid dependent patients' experiences of and attitudes towards having their injecting sites examined
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Australia
    Int J Drug Policy 20:85-9. 2009
  7. doi Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia
    Adam R Winstock
    Sydney South West Area Health Service, Drug Health Services, Locked Bag 4002, Ashfield, NSW 2131, Australia
    Int J Drug Policy 19:450-8. 2008
  8. ncbi Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
    Med J Aust 191:161-5. 2009
  9. doi What is diversion of supervised buprenorphine and how common is it?
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, New South Wales, Australia
    J Addict Dis 28:269-78. 2009
  10. doi Methods and motivations for buprenorphine diversion from public opioid substitution treatment clinics
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, New South Wales, Australia adam
    J Addict Dis 28:57-63. 2009

Detail Information

Publications15

  1. ncbi 4-MTA: a new synthetic drug on the dance scene
    Adam R Winstock
    National Addiction Centre, Institute of Psychiatry, Addiction Sciences Building, 4 Windsor Walk, SE5 8AF, London, UK
    Drug Alcohol Depend 67:111-5. 2002
    ..Responses to the effects of the drug were mixed, although about a quarter of those who believed that they had tried 4-MTA thought that they would use it again...
  2. doi Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study
    A R Winstock
    National Drug and Alcohol Research Centre, University of New South Wales, and Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
    J Psychopharmacol 23:84-93. 2009
    ..This study provides evidence for the potential clinical utility and safety of lithium in the management of cannabis withdrawal. A randomised, placebo-controlled trial is recommended...
  3. doi Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, Australia
    Drug Alcohol Rev 27:393-7. 2008
    ..Clients in opioid substitution therapy often have considerable unmet health-care needs. The current study aimed to explore health problems related to opioid substitution therapy among clients on methadone and buprenorphine treatment...
  4. ncbi The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Australia
    Drug Alcohol Rev 26:411-6. 2007
    ....
  5. ncbi Safe storage of methadone takeaway doses - a survey of patient practice
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Ashfield, New South Wales, Australia
    Aust N Z J Public Health 31:526-8. 2007
    ..To determine current methadone takeaway storage practice among patients receiving supervised methadone treatment and takeaway doses at community pharmacies...
  6. doi Opioid dependent patients' experiences of and attitudes towards having their injecting sites examined
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Australia
    Int J Drug Policy 20:85-9. 2009
    ....
  7. doi Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia
    Adam R Winstock
    Sydney South West Area Health Service, Drug Health Services, Locked Bag 4002, Ashfield, NSW 2131, Australia
    Int J Drug Policy 19:450-8. 2008
    ..This study aimed to investigate the prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid pharmacotherapy treatment at community pharmacies in New South Wales (NSW), Australia...
  8. ncbi Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
    Med J Aust 191:161-5. 2009
    ..Comparison was made with injecting of two other opioid substitution treatment medications, methadone and buprenorphine (BPN); severe harms have been documented after injection of the latter...
  9. doi What is diversion of supervised buprenorphine and how common is it?
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, New South Wales, Australia
    J Addict Dis 28:269-78. 2009
    ..69), and having more buprenorphine clients (odds ratio = 1.24). Future research investigating the prevalence of buprenorphine diversion should include a clear definition of what behaviors constitute diversion...
  10. doi Methods and motivations for buprenorphine diversion from public opioid substitution treatment clinics
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, New South Wales, Australia adam
    J Addict Dis 28:57-63. 2009
    ..Responses to suspected diversion should aim to minimise harm and maximise treatment outcomes...
  11. doi Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, NSW, Australia
    Addiction 105:335-42. 2010
    ..To explore service provision and the range of problems that New South Wales (NSW) and Victoria (VIC) community pharmacists providing opioid substitution treatment (OST) have experienced with clients and prescribers...
  12. ncbi National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, NSW
    Med J Aust 184:560-2. 2006
    ..To identify the prevalence of blood-borne viruses (BBVs) testing, counselling and vaccination services by drug and alcohol services for injecting drug users in Australia...
  13. doi Evaluation of a training program to improve clinicians' assessment of patient stability
    Adam R Winstock
    Drug Health Services, Sydney South West Area Health Service, Sydney, Australia
    Drug Alcohol Rev 28:353-9. 2009
    ..A two-hour clinical training program was delivered to staff at 31 public clinics, that aimed to improve staff confidence in assessing client stability, and skills in negotiating the transfer of clients to community pharmacies...
  14. doi Buprenorphine use by the smoking route in gaols in NSW
    Adam R Winstock
    Drug Alcohol Rev 27:449-50. 2008
  15. pmc High risk groups are still not being vaccinated
    Adam R Winstock
    BMJ 330:198; author reply 198. 2005